CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $49,999,983
- in 2 filings
- Open-market sales, last 90 days
- $215,781
- in 9 filings
Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 41 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-09 | Shook David Chief Medical Officer | Grant or award | +21,900 | 21,900 | ||
| 2025-06-09 | Shook David Chief Medical Officer | Grant or award · Option (right to buy) | +43,750 | 43,750 | ||
| 2025-05-15 | Klausner Richard Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2025-05-15 | RIEFLIN WILLIAM JL Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2025-05-15 | FRIEDMAN CATHY Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2025-05-15 | BRAWLEY OTIS W Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2025-05-15 | NABEL ELIZABETH G Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2025-05-15 | Ramachandra Sumant Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2025-03-31 | BRAWLEY OTIS W Director | Purchase | +35,640 | $0.56 | $20K | 35,640 |
| 2025-03-21 | Ramachandra Sumant Director | Purchase | +200,000 | $0.58 | $115K | 200,000 |
| 2025-03-17 | Newton Charles W. Chief Financial Officer | Purchase | +200,000 | $0.56 | $112K | 200,000 |
| 2025-03-14 | Klausner Richard Director | Purchase | +158,000 | $0.60 | $95K | 843,365 |
| 2025-03-14 | Seely Lynn President and CEO | Purchase | +175,000 | $0.61 | $106K | 712,500 |
| 2025-02-10 | Lang Matthew Chief Business Officer | Grant or award | +112,500 | 162,500 | ||
| 2025-02-10 | Lang Matthew Chief Business Officer | Grant or award · Option (right to buy) | +450,000 | 450,000 | ||
| 2025-02-10 | Lang Matthew Chief Business Officer | Grant or award · Option (right to buy) | +56,250 | 56,250 | ||
| 2025-02-10 | Seely Lynn President and CEO | Grant or award | +337,500 | 537,500 | ||
| 2025-02-10 | Seely Lynn President and CEO | Grant or award · Option (right to buy) | +1,350,000 | 1,350,000 | ||
| 2025-02-10 | Seely Lynn President and CEO | Grant or award · Option (right to buy) | +168,750 | 168,750 | ||
| 2025-02-10 | Hill Stephen J. Chief Operating Officer | Grant or award | +112,500 | 172,899 |
Page 5 of 8 · 156 trades